VANGUARD GROUP INC 13D/13G Filings for Anika Therapeutics, Inc. (ANIK)

VANGUARD GROUP INC 13D and 13G filings for Anika Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-13
4:58 pm
Sale		2023-12-2913GAnika Therapeutics, Inc.
ANIK		VANGUARD GROUP INC764,045
5.220%		-219,723decrease
(-22.33%)		Filing
2023-02-09
11:07 am
Purchase		2022-12-3013GAnika Therapeutics, Inc.
ANIK		VANGUARD GROUP INC983,768
6.730%		17,855increase
(+1.85%)		Filing
2022-02-09
3:24 pm
Purchase		2021-12-3113GAnika Therapeutics, Inc.
ANIK		VANGUARD GROUP INC965,913
6.690%		31,631increase
(+3.39%)		Filing
2021-02-10
10:30 am
Purchase		2020-12-3113GAnika Therapeutics, Inc.
ANIK		VANGUARD GROUP INC934,282
6.570%		18,686increase
(+2.04%)		Filing